Current Therapy for Prostate Cancer
Focus on Goserelin - Proceedings of the Zoladex International Symposium, Kobe, Japan, 20-21 September 1991
Published in December 1992
Book
Hardback
166 pages
978-0-444-89807-4 (ISBN)
Description
Cancer of the prostate has been recognized over the past decade as the most common form of cancer in males. This book summarizes the conditions and concerns relating to existing methods of treating prostate cancer, such as surgery, radiation, chemotherapy, and chemoendocrine therapy. It also covers the results of clinical trials of Zoladex (a biodegradable sustained-release depot formulation of a luteinizing hormone-releasing hormone agonist analogue, goserelin acetate) held in Japan, and includes accounts of the wide experience obtained in Europe and the USA with this drug. New trends and developments in the field of prostate cancer treatment worldwide are also discussed. Aimed primarily at oncologists and urologists, this book will be of great value to all those currently active in the field of prostate cancer.
Cancer of the prostate has been recognized over the past decade as the most common form of cancer in males. This book summarizes the conditions and concerns relating to existing methods of treating prostate cancer, such as surgery, radiation, chemotherapy, and chemoendocrine therapy. It also covers the results of clinical trials of Zoladex (a biodegradable sustained-release depot formulation of a luteinizing hormone-releasing hormone agonist analogue, goserelin acetate) held in Japan, and includes accounts of the wide experience obtained in Europe and the USA with this drug. New trends and developments in the field of prostate cancer treatment worldwide are also discussed. Aimed primarily at oncologists and urologists, this book will be of great value to all those currently active in the field of prostate cancer.
Cancer of the prostate has been recognized over the past decade as the most common form of cancer in males. This book summarizes the conditions and concerns relating to existing methods of treating prostate cancer, such as surgery, radiation, chemotherapy, and chemoendocrine therapy. It also covers the results of clinical trials of Zoladex (a biodegradable sustained-release depot formulation of a luteinizing hormone-releasing hormone agonist analogue, goserelin acetate) held in Japan, and includes accounts of the wide experience obtained in Europe and the USA with this drug. New trends and developments in the field of prostate cancer treatment worldwide are also discussed. Aimed primarily at oncologists and urologists, this book will be of great value to all those currently active in the field of prostate cancer.
More details
Series
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 230 mm
Weight
514 gr
ISBN-13
978-0-444-89807-4 (9780444898074)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Preface. Current Treatment of Prostate Cancer and Associated Problems. 1. Local treatment. Treatment of localized prostate cancer: Current status and problems (S. Isaka, J. Shimazaki). 2. Systemic treatment. Present status and problems of endocrine therapy for prostate cancer (K. Oishi). Current status and problems of chemohormonal therapy in the treatment of prostate cancer (S. Naito). Chemotherapy for advanced prostate cancer (Y. Hirao). New Endocrine Therapy Based on Goserelin. Goserelin: Pharmacology, mode of action, and preclinical tumor studies (B.J.A. Furr, F.G. Hutchinson). Clinical experience with goserelin (R.A.V. Milsted). Clinical Experience with Goserelin in Japan. Results of phase I and II studies of goserelin in Japan (H. Akaza). Clinical efficacy and safety of goserelin (Y. Saito). A multicenter clinical trial of goserelin: A comparison with castration or estrogen and its efficacy during long-term treatment (M. Usami, Zoladex Multicenter Study Group). Clinical Experience with Goserelin in Europe and the USA. Goserelin: The European experience (L.J. Denis). Androgen deprivation for locally advanced and metastatic prostate cancer (M.S. Soloway). Adapting goserelin for clinical practice (D.W.W. Newling). Future of Prostate Cancer Treatment. Prostate cancer: Past, present and future (A.V. Kaisary). Discussion. Treatment of prostate cancer: Focus on goserelin. Author Index.